Prelude Capital Management’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-25,000
Closed -$445K 2375
2021
Q4
$445K Hold
25,000
0.01% 1085
2021
Q3
$353K Buy
+25,000
New +$389K 0.01% 1058

Other funds holding NXGN

Prelude Capital Management's NXGN Position: Q4 2023 in Review

Prelude Capital Management sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 34,136 shares — an estimated $810K sold.

Prelude Capital Management first reported a position in NXGN in Q2 2014 and held it in 28 quarters. The position peaked at $810K in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • Prelude Capital Management reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Prelude Capital Management sold 34,136 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $810K.
  • Prelude Capital Management first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2014 and held it in 28 quarters.
  • Prelude Capital Management's NextGen Healthcare, Inc. Common Stock position peaked at $810K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.